Development of instrument to report and asses causality of adverse events related to herbal medicines
DOI:
https://doi.org/10.17533/udea.vitae.v24n1a02Keywords:
Herbal medicine, adverse drug reaction reporting systems, pharmacovigilance, risk assessment, product Surveillance, postmarketing.Abstract
Background: The use of herbal medicines is justified empirically using ethnopharmacological knowledge, which has limitations. Reports of adverse events (AE) may contribute for safety, quality, and effectiveness assessment. Objectives: This study aimed to develop an instrument to allow detection and evaluation of the causal likelihood of AE related to herbal medicines. Methods: A quantitative methodological development research intervention was performed with primary care health professionals. Two cases were distributed in an interval of one week in order to allow for completion of the proposal form. The within-rater reliability was calculated and classified into satisfactory, regular, and unsatisfactory, according to essential, necessary, and recommended items reported. Results: Fifty-seven professionals were enrolled. A high degree of the within-rater reliability was observed for the most essential, necessary, and recommended fields. The instrument contributed to assessment of definite causal association, once the duration of reactions including evolution, withdrawal, and reposition items showed high reliability. Most fields poor and weak filled were related to quality defects, such as popular name and appearance. Conclusions: Data suggest the instrument is adequate to report AE arising from herbal medicines. Owing to information regarding to organoleptic characteristics, the instrument is different from drug instruments. Therefore, it is intended to improve AE reports related to herbal medicines and contribute for appropriate use.
Downloads
References
Rodrigues E, Barnes J. Pharmacovigilance of herbal medicines. The potentioal contributions of ethnobotanical and ethnopharmacological studies. Drug Saf ety. 2013; 36:1-12.
Balbino EE, Dias MF. Farmacovigilância: um passo em direção ao uso racional de plantas medicinais e fitorápicos. Revista Brasileira de Farmacognosia. 2010; 20(6): 992-1000.
Menniti-Ippolito F, Mazzanti G, Santuccio C, Moro PA, Calapai G, Firenzuoli F, et al. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiology and Drug Safety. 2008; 17: 626-635.
Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. British Journal of Clinical Pharmacology. 1998; 45: 496-500.
Hopf Y, Watson M, Williams D. Adverse Drug Reaction related admissions to a hospital in Scotland. Pharmacy World and Science. 2008; 30: 854-862.
Lanini J, Duarte-Almeida JM, Nappo S, Carlini EA. O que vêm da terra não faz mal. Relatos de problemas relacionados ao uso de plantas medicinais por raizeiros de Diadema/SP. Revista Brasileira de Farmacognosia. 2009; 19(1A): 121-129.}
Shaw D. Toxicological risks of Chinese herbs. Planta Medica. 2010; 76: 2012-2010.
Soares-Neto JAR, Galduróz JCF, Rodrigues E. A rede de comércio popular de drogas psicoativas na cidade de Diadema e o seu interesse para a Saúde Pública. Saúde Soc. 2010, 19: 310-319.
Soares-Neto JAR, Kato EM, Bugno A, Galduróz JCF, Marques LC, Macrini T, et al. Informal trade of psychoactive
herbal products in the city of Diadema, SP, Brazil: quality and potential risks. J Evid Based Complem Altern Med, 2013. doi: 10.1155/2013/894834
Adusumilli PS, Lee B, Parekh K, Farrelly PA. Acalculuos eosinophilic cholecystitis from herbal medicine: a review of adverse effects of herbal medicine in surgical patients. Surgery. 2002; 131: 352-356.
Van Hunsel FP, van Grootheest AC. Adverse reactions to herbal remedies: analysis of reported adverse reactions in the Nerthelands. Nederlands Tijdschrift voor Geneeskunde 2013; 157(47):A6615.
Pagotto C, Varallo FR, Mastroianni PC. Impact of Educational Interventions on Adverse Drug Events Reporting. International Journal of Technology Assessment of Health Care. 2013; 29 (4) 410-417.
Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueira A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013; 36(5):317-328.
Tabach R, De Santi D, Movilla J, Mattos P, Carlini EA. Boletim PLANFAVI 1ª edição. Sistema de Farmacovigilância de Plantas Medicinais. CEBRID, 2007.
Soares-Neto JA, Galduróz JC, Marques LC, Kato ET, Macrini T, Rodrigues E. Possible adverse reactions to herbal products: a study with individuals who report to popular medicine in the city of Diadema, SP, Brazil. Phytother Res. 2014, 28: 405-11.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Vitae
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
